Koarada Syuichi, Tada Yoshifumi, Suematsu Rie, Soejima Sachiko, Inoue Hisako, Ohta Akihide, Nagasawa Kohei
Division of Rheumatology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Clin Dev Immunol. 2012;2012:198206. doi: 10.1155/2012/198206. Epub 2011 Sep 26.
This study aimed to investigate phenotype of RP105(-) B cell subsets in patients with systemic lupus erythematosus (SLE). Flow cytometry was used for phenotyping RP105-negaive B cell subsets. Based on CD19, RP105, and CD138 expression, RP105(-) B cells consist of at least 5 subsets of late B cells, including CD19(+)RP105(int), CD19(+) RP105(-), CD19(low) RP105(-) CD138(-), CD19(low) RP105(-)CD138(int), and CD19(low) RP105(-) CD138(++) B cells. Especially, CD19(+)RP105(int) and CD19(low) RP105(-)CD138(int) B cells are significantly larger than other RP105(-) B cell subsets in SLE. By comparison of RP105(-) B cell subsets between patients with SLE and normal subjects, these subsets were detectable even in normal subjects, but the percentages of RP105(-) B cell subsets were significantly larger in SLE. The phenotypic analysis of RP105(-) B cell subsets suggests dysregulation of later B cell subsets in SLE and may provide new insights into understanding regulation of B cells in human SLE.
本研究旨在调查系统性红斑狼疮(SLE)患者中RP105阴性B细胞亚群的表型。采用流式细胞术对RP105阴性B细胞亚群进行表型分析。基于CD19、RP105和CD138的表达,RP105阴性B细胞至少由5个晚期B细胞亚群组成,包括CD19(+)RP105(int)、CD19(+)RP105(-)、CD19(low)RP105(-)CD138(-)、CD19(low)RP105(-)CD138(int)和CD19(low)RP105(-)CD138(++)B细胞。特别是,在SLE中,CD19(+)RP105(int)和CD19(low)RP105(-)CD138(int)B细胞明显大于其他RP105阴性B细胞亚群。通过比较SLE患者和正常受试者的RP105阴性B细胞亚群,发现这些亚群在正常受试者中也可检测到,但SLE中RP105阴性B细胞亚群的百分比明显更高。RP105阴性B细胞亚群的表型分析表明SLE中晚期B细胞亚群存在失调,可能为理解人类SLE中B细胞的调节提供新的见解。